TY - JOUR
T1 - Hodgkin disease/lymphoma
T2 - Clinical practice guidelines in oncology™
AU - Hoppe, Richard T.
AU - Advani, Ranjana Hira
AU - Bierman, Philip J.
AU - Bloomfield, Clara D.
AU - Buadi, Francis
AU - Djulgegovic, Benjamin
AU - Forero, Andres
AU - Gordon, Leo I.
AU - Hernandez-Ilizaliturri, Francisco J.
AU - Kaminski, Mark S.
AU - Love, Gena
AU - Maloney, David G.
AU - Mauch, Peter M.
AU - Moore, Joseph O.
AU - Schilder, Russell J.
AU - Weiss, Lawrence
AU - Winter, Jane N.
AU - Yahalom, Joachim
AU - Zelenetz, Andrew D.
PY - 2006/3
Y1 - 2006/3
N2 - The management of HD continues to evolve, and the NCCN guidelines have undergone major changes since their inception. Current management programs are based on comprehensive clinical staging followed by combined modality therapy for patients with favorable and intermediate prognosis, or chemotherapy alone for patients with advanced disease. Relapse is uncommon, but secondary management with peripheral stem cell transplantation may be effective. The excellent prognosis for these patients mandates careful long-term follow-up to detect late treatment effects.
AB - The management of HD continues to evolve, and the NCCN guidelines have undergone major changes since their inception. Current management programs are based on comprehensive clinical staging followed by combined modality therapy for patients with favorable and intermediate prognosis, or chemotherapy alone for patients with advanced disease. Relapse is uncommon, but secondary management with peripheral stem cell transplantation may be effective. The excellent prognosis for these patients mandates careful long-term follow-up to detect late treatment effects.
KW - Classical HD
KW - Combined modality therapy
KW - Hodgkin disease
KW - Lymphocyte predominance
KW - Lymphoma
KW - NCCN Clinical Practice Guidelines
UR - http://www.scopus.com/inward/record.url?scp=33645933906&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33645933906&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2006.0021
DO - 10.6004/jnccn.2006.0021
M3 - Review article
C2 - 16507269
AN - SCOPUS:33645933906
SN - 1540-1405
VL - 4
SP - 210
EP - 230
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 3
ER -